Suchergebnisse - (Subject:"Severe Acute Respiratory Syndrome")

PubPharm (3.113)

21

Betacoronavirus Infection Outbreak, São Paulo, Brazil, Fall 2023

enthalten in: Emerging infectious diseases | 2024

von Chaves, T. | Perosa, A. | Barbosa, G. | +2

22

Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan

enthalten in: Emerging infectious diseases | 2024

von Lee, C. | Kuo, H. | Liu, Y. | +2

23

Emerging role of N6-methyladenosine RNA modification in regulation of SARS-CoV-2 infection and virus-host interactions

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Liu, J. | Chen, L. | Guo, X. | +2

24

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients : The RECOVAC LESS CoV-2 Study - Long Term Efficacy and Safety of SARS-CoV-2 Vaccination in Patients in Patients With Chronic Kidney Disease Stage G4-G5, on Dialysis or After Kidney Transplantation

enthalten in: ClinicalTrials.gov | 2024

25

KIDney Injury in Times of COVID-19 (KIDCOV) : The KIDCOV Study: ASSESSMENT of SARS-CoV-2 Without HOSPITALIZATION as a RISK FACTOR for ACUTE KIDNEY INJURY

enthalten in: ClinicalTrials.gov | 2024

26

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults : Systematic Literature Review and Meta-Analysis Using the GRADE Framework

enthalten in: Infectious diseases and therapy | 2024

von Kavikondala, S. | Haeussler, K. | Wang, X. | +8

27

Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection

enthalten in: Emerging infectious diseases | 2024

von Vu, Q. | Fitzpatrick, A. | Cope, J. | +5

28

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children : A MASTER PHASE 1/2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF VARIANT-ADAPTED BNT162b2 RNA-BASED VACCINE CANDIDATE(S) IN HEALTHY CHILDREN

enthalten in: ClinicalTrials.gov | 2024

29

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 : Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

enthalten in: ClinicalTrials.gov | 2024

30

Northeast COVID-19 and Pregnancy Study Group : Clinical and Laboratory Predictors of COVID-19 Progression and Maternal and Perinatal Outcomes in Infected Pregnant and Postpartum Women in Six Reference Centers in the Northeast of Brazil

enthalten in: ClinicalTrials.gov | 2024